These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9840289)

  • 1. Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein.
    Corallini A; Betti M; Rusnati M; Campioni D; Ciomei M; Sola F; Calza N; Zauli G; Presta M; Barbanti-Brodano G; Caputo A
    AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1561-71. PubMed ID: 9840289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
    Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M
    FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model.
    Possati L; Campioni D; Sola F; Leone L; Ferrante L; Trabanelli C; Ciomei M; Montesi M; Rocchetti R; Talevi S; Bompadre S; Caputo A; Barbanti-Brodano G; Corallini A
    Clin Exp Metastasis; 1999; 17(7):575-82. PubMed ID: 10845556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists.
    Rusnati M; Tulipano G; Urbinati C; Tanghetti E; Giuliani R; Giacca M; Ciomei M; Corallini A; Presta M
    J Biol Chem; 1998 Jun; 273(26):16027-37. PubMed ID: 9632653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.
    Rusnati M; Coltrini D; Oreste P; Zoppetti G; Albini A; Noonan D; d'Adda di Fagagna F; Giacca M; Presta M
    J Biol Chem; 1997 Apr; 272(17):11313-20. PubMed ID: 9111037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis.
    Misumi S; Takamune N; Ohtsubo Y; Waniguchi K; Shoji S
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):297-304. PubMed ID: 15117453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice.
    Rusnati M; Coltrini D; Campioni D; Tanghetti E; Corallini A; Barbanti-Brodano G; Giuliani R; Gibellini D; Presta M
    AIDS; 1997 May; 11(6):727-36. PubMed ID: 9143604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice.
    Corallini A; Campioni D; Rossi C; Albini A; Possati L; Rusnati M; Gazzanelli G; Benelli R; Masiello L; Sparacciari V; Presta M; Mannello F; Fontanini G; Barbanti-Brodano G
    AIDS; 1996 Jun; 10(7):701-10. PubMed ID: 8805860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.
    Kolson DL; Collman R; Hrin R; Balliet JW; Laughlin M; McGann KA; Debouck C; Gonzalez-Scarano F
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1927-34. PubMed ID: 8046394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.
    Bugatti A; Urbinati C; Ravelli C; De Clercq E; Liekens S; Rusnati M
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2337-45. PubMed ID: 17452490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
    Jeyaseelan R; Kurabayashi M; Kedes L
    AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 Tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity.
    Corallini A; Sampaolesi R; Possati L; Merlin M; Bagnarelli P; Piola C; Fabris M; Menegatti MA; Talevi S; Gibellini D; Rocchetti R; Caputo A; Barbanti-Brodano G
    Virology; 2002 Jul; 299(1):1-7. PubMed ID: 12167335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
    New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct interaction of human TFIID with the HIV-1 transactivator tat.
    Kashanchi F; Piras G; Radonovich MF; Duvall JF; Fattaey A; Chiang CM; Roeder RG; Brady JN
    Nature; 1994 Jan; 367(6460):295-9. PubMed ID: 8121496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody defines a novel HIV type 1 Tat domain involved in trans-cellular trans-activation.
    Valvatne H; Szilvay AM; Helland DE
    AIDS Res Hum Retroviruses; 1996 May; 12(7):611-9. PubMed ID: 8743086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB.
    Veschambre P; Roisin A; Jalinot P
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2235-45. PubMed ID: 9292011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in tumor angiogenesis associated with stable expression of the HIV tat gene.
    Huber BE; Richards CA; Martin JL; Wirth PJ
    Mol Carcinog; 1992; 5(4):293-300. PubMed ID: 1379815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
    Lisziewicz J; Rappaport J; Dhar R
    New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.